Nitazoxanide (NTZ)

DRUG3 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Tanta University

Conditions

HIV InfectionHepatitis C InfectionSBP - Spontaneous Bacterial PeritonitisUlcerative Colitis (UC)

Phase 1

Nitazoxanide in Spontaneous Bacterial Peritonitis

Not yet recruitingNCT07808450

Tanta UniversitySBP - Spontaneous Bacterial Peritonitis

Start: 2026-09-01End: 2027-09-01Target: 60Updated: 2026-09-08

Phase 2

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

CompletedNCT00991289

National Institute of Allergy and Infectious Diseases (NIAID)Hepatitis C Infection, HIV Infection

Start: 2010-01-31End: 2012-01-31Updated: 2021-11-04

Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis

Not yet recruitingNCT07820046

Tanta UniversityUlcerative Colitis (UC)

Start: 2027-01-01End: 2028-01-01Target: 44Updated: 2026-09-15